Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' KANZ L' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 289 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dittmann, H; Sokler, M; Kollmannsberger, C; Dohmen, BM; Baumann, C; Kopp, A; Bares, R; Claussen, CD; Kanz, L; Bokemeyer, C
      Comparison of (18)FDG-PET with CT scans in the evaluation of patients withresidual and recurrent Hodgkin's lymphoma

      ONCOLOGY REPORTS
    2. Hartmann, JT; Einhorn, L; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Schmoll, HJ; Kanz, L; Bokemeyer, C
      Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results of an international multicenter analysis

      JOURNAL OF CLINICAL ONCOLOGY
    3. Bokemeyer, C; Gillis, AJM; Pompe, K; Mayer, F; Metzner, B; Schleucher, N; Schleicher, J; Pflugrad-Jauch, G; Oosterhuis, JW; Kanz, L; Looijenga, LHJ
      Clinical impact of germ cell tumor cells in apheresis products of patientsreceiving high-dose chemotherapy

      JOURNAL OF CLINICAL ONCOLOGY
    4. Rick, O; Bokemeyer, C; Beyer, J; Hartmann, JT; Schwella, N; Kingreen, D; Neureither, S; Metzner, B; Casper, J; Wandt, H; Hartmann, F; Schmoll, HJ; Derigs, G; Gerl, A; Berdel, WE; Kanz, L; Siegert, W
      Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer

      JOURNAL OF CLINICAL ONCOLOGY
    5. Kollmannsberger, C; Mayer, F; Kuczyk, M; Kanz, L; Bokemeyer, C
      Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy

      WORLD JOURNAL OF UROLOGY
    6. Brossart, P; Wirths, S; Brugger, W; Kanz, L
      Dendritic cells in cancer vaccines

      EXPERIMENTAL HEMATOLOGY
    7. Hebart, H; Wuchter, P; Loeffler, J; Gscheidle, B; Hamprecht, K; Sinzger, C; Jahn, G; Dietz, K; Kanz, L; Einsele, H
      Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant

      BONE MARROW TRANSPLANTATION
    8. Schafer, H; Berger, C; Aepinus, C; Hebart, H; Beck, R; Kaiserling, E; Kanz, L; Einsele, H; Knecht, H
      Molecular pathogenesis of Epstein-Barr virus associated posttransplant lymphomas: New insights through latent membrane protein 1 fingerprinting

      TRANSPLANTATION
    9. Kanz, L; Brugger, W
      Retraction: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. (vol 333, pg 283, 1995)

      NEW ENGLAND JOURNAL OF MEDICINE
    10. Brossart, P; Schneider, A; Dill, P; Schammann, T; Grunebach, F; Wirths, S; Kanz, L; Buhring, HJ; Brugger, W
      The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-Lymphocytes

      CANCER RESEARCH
    11. Bokemeyer, C; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Schmoll, HJ; Kanz, L; Einhorn, L; Nichols, CR; Hartmann, JT
      Extragonadal seminoma - An international multicenter analysis of prognostic factors and long term treatment outcome

      CANCER
    12. Herrlinger, U; Schabet, M; Brugger, W; Kortmann, RD; Kanz, L; Bamberg, M; Dichgans, J; Weller, M
      Primary central nervous system lymphoma 1991-1997 - Outcome and late adverse effects after combined modality treatment

      CANCER CYTOPATHOLOGY
    13. Herrlinger, U; Schabet, M; Brugger, W; Kortmann, RD; Kanz, L; Bamberg, M; Dichgans, J; Weller, M
      Primary central nervous system lymphoma 1991-1997 - Outcome and late adverse effects after combined modality treatment

      CANCER
    14. Manz, M; Riessen, R; Poll, L; Dohmen, B; Kaiserling, E; Kruck, W; Laniado, M; Kanz, L; Denzlinger, C
      High-grade lymphoma mimicking bone crisis in Gaucher's disease

      BRITISH JOURNAL OF HAEMATOLOGY
    15. Kleihauer, A; Grigoleit, U; Hebart, H; Moris, A; Brossart, P; Muhm, A; Stevanovic, S; Rammensee, HG; Sinzger, C; Riegler, S; Jahn, G; Kanz, L; Einsele, H
      Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells

      BRITISH JOURNAL OF HAEMATOLOGY
    16. Hartmann, JT; von Vangerow, A; Fels, LM; Knop, S; Stolte, H; Kanz, L; Bokemeyer, C
      A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplanation

      BRITISH JOURNAL OF CANCER
    17. Seiffert, M; Brossart, P; Cant, C; Cella, M; Colonna, M; Brugger, W; Kanz, L; Ullrich, A; Buhring, HJ
      Signal-regulatory protein alpha (SIRP alpha) but not SIRP beta is involvedin T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells

      BLOOD
    18. Hebart, H; Brugger, W; Grigoleit, U; Gscheidle, B; Loeffler, J; Schafer, H; Kanz, L; Einsele, H; Sinzger, C
      Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality

      BLOOD
    19. Bautz, F; Denzlinger, C; Kanz, L; Mohle, R
      Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1

      BLOOD
    20. Buhring, HJ; Seiffert, M; Giesert, C; Marxer, A; Kanz, L; Valent, P; Sano, K
      The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3

      BLOOD
    21. Kotter, I; Aepinus, C; Graepler, F; Gartner, V; Eckstein, AK; Stubiger, N; Kaskas, B; Zierhut, M; Bultmann, B; Kandolf, R; Kanz, L
      HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatmentwith cyclosporin A, azathioprine, and prednisolone for ocular Behcet's disease and complete remission of both disorders with interferon alpha

      ANNALS OF THE RHEUMATIC DISEASES
    22. Hartmann, JT; Fossa, SD; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Beyer, J; Pont, J; Fizazi, K; Hecker, H; Kanz, L; Einhorn, L; Bokemeyer, C
      Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    23. Kugler, A; Stuhler, G; Walden, P; Zoller, G; Zobywalski, A; Brossart, P; Trefzer, U; Ullrich, S; Muller, CA; Becker, V; Gross, AJ; Hemmerlein, B; Kanz, L; Muller, GA; Ringert, RH
      Regression of human metastatic renal cell carcinoma after vaccination withtumor cell-dendritic cell hybrids

      NATURE MEDICINE
    24. Vogel, W; Scheding, S; Kanz, L; Brugger, W
      Clinical applications of CD34(+) peripheral blood progenitor cells (PBPC)

      STEM CELLS
    25. Kollmannsberger, C; Gerl, A; Schleucher, N; Beyer, J; Kuczyk, M; Rick, O; Gasper, J; Sosada, M; Rie, C; Kanz, L; Bokemeyer, C
      Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer

      ANTI-CANCER DRUGS
    26. Hartmann, JT; Knop, S; Fels, LM; van Vangerow, A; Stolte, H; Kanz, L; Bokemeyer, C
      The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors

      ANTI-CANCER DRUGS
    27. Hebart, H; Loeffler, J; Kanz, L; Einsele, H
      Molecular methods in the diagnosis of infections in the immunocompromised host

      CURRENT OPINION IN INFECTIOUS DISEASES
    28. Bethge, W; Guggenberger, D; Bamberg, M; Kanz, L; Bokemeyer, C
      Thyroid toxicity of treatment for Hodgkin's disease

      ANNALS OF HEMATOLOGY
    29. Kollmannsberger, C; Nichols, C; Meisner, C; Mayer, F; Kanz, L; Bokemeyer, C
      Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: An explorative analysis using cart modeling

      ANNALS OF ONCOLOGY
    30. Kollmannsberger, C; Nichols, C; Bamberg, M; Hartmann, JT; Schleucher, N; Beyer, J; Schoffski, P; Derigs, G; Ruther, U; Bohlke, I; Schmoll, HJ; Kanz, L; Bokemeyer, C
      First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases

      ANNALS OF ONCOLOGY
    31. Bokemeyer, C; Kollmannsberger, C; Hartmann, JT; Kanz, L
      Follow up after primary treatment: curable diseases treated non-surgically

      ANNALS OF ONCOLOGY
    32. Bokemeyer, C; Hartmann, JT; Mayer, F; Bohlke, I; Kanz, L; von Pawel, J; Derigs, G; Schroder, M
      UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumors

      ONCOLOGY-NEW YORK
    33. Gunaydin, I; Pereira, PL; Daikeler, T; Mohren, M; Trubenbach, J; Schick, F; Kanz, L; Kotter, I
      Magnetic resonance imaging guided corticosteroid injection of the sacroiliac joints in patients with therapy resistant spondyloarthropathy: A pilot study

      JOURNAL OF RHEUMATOLOGY
    34. Bautz, F; Rafii, S; Kanz, L; Mohle, R
      Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells: Possible role in the hematopoietic microenvironment

      EXPERIMENTAL HEMATOLOGY
    35. Kratz-Albers, K; Scheding, S; Mohle, R; Buhring, HJ; Baum, CM; Mc Kearn, JP; Buchner, T; Kanz, L; Brugger, W
      Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin

      EXPERIMENTAL HEMATOLOGY
    36. Schafer, H; Bader, P; Kaiserling, E; Klingebiel, T; Handgretinger, R; Kanz, L; Einsele, H
      Extramedullary relapses at uncommon sites after allogeneic stem cell transplantation

      BONE MARROW TRANSPLANTATION
    37. Einsele, H; Hebart, H; Kauffman-Schneider, C; Sinzger, C; Jahn, G; Bader, P; Klingebiel, T; Dietz, K; Loffler, J; Bokemeyer, C; Muller, CA; Kanz, L
      Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

      BONE MARROW TRANSPLANTATION
    38. Hartmann, JT; Fels, LM; Franzke, A; Knop, S; Renn, M; Maess, B; Panagiotou, P; Lampe, H; Kanz, L; Stolte, H; Bokemeyer, C
      Comparative study of the acute nephrotoxicity from standard dose cisplatin+/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide

      ANTICANCER RESEARCH
    39. Hartmann, JT; Kanz, L; Bokemeyer, C
      Phase II study of continuous 120-hour- infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma

      ANTICANCER RESEARCH
    40. Hartmann, JT; Fels, LM; Knop, S; Stolte, H; Kanz, L; Bokemeyer, C
      A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors

      INVESTIGATIONAL NEW DRUGS
    41. Braun, N; Faul, C; Wernet, D; Schnaidt, M; Stuhler, G; Kanz, L; Risler, T; Einsele, H
      Successful transplantation of highly selected CD34+peripheral blood stem cells in a HLA-sensitized patient treated with immunoadsorption onto proteinA

      TRANSPLANTATION
    42. Brugger, W; Scheding, S; Ziegler, B; Buhring, HJ; Kanz, L
      Ex vivo manipulation of hematopoietic stem and progenitor cells

      SEMINARS IN HEMATOLOGY
    43. Machann, J; Pereira, PL; Einsele, H; Kanz, L; Claussen, CD; Schick, F
      MR Characterization of the hemapoetic bone marrow. Findings in generalizedneoplasia and treatment monitoring

      RADIOLOGE
    44. Hebart, H; Loffler, J; Meisner, C; Serey, F; Schmidt, D; Bohme, A; Martin, H; Engel, A; Bunjes, D; Kern, WV; Schumacher, U; Kanz, L; Einsele, H
      Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening

      JOURNAL OF INFECTIOUS DISEASES
    45. Brossart, P; Zobywalski, A; Grunebach, F; Behnke, L; Stuhler, G; Reichardt, VL; Kanz, L; Brugger, W
      Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells

      CANCER RESEARCH
    46. Hartmann, JT; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Einhorn, L; Kanz, L; Bokemeyer, C
      The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors

      CANCER
    47. Hebart, H; Loffler, J; Reitze, H; Engel, A; Schumacher, U; Klingebiel, T; Bader, P; Bohme, A; Martin, H; Bunjes, D; Kern, WV; Kanz, L; Einsele, H
      Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia

      BRITISH JOURNAL OF HAEMATOLOGY
    48. Mohle, R; Schittenhelm, M; Failenschmid, C; Bautz, F; Kratz-Albers, K; Serve, H; Brugger, W; Kanz, L
      Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    49. Beck, R; Neipel, F; Canji, B; Hebart, H; Kanz, L; Jahn, G; Einsele, H
      Absence of human herpesvirus 8 DNA sequences in leucapheresis products andbone marrow samples of patients with advanced multiple myeloma

      BRITISH JOURNAL OF HAEMATOLOGY
    50. Denzlinger, C; Bowen, D; Benz, D; Gelly, K; Brugger, W; Kanz, L
      Low-dose melphalan induces favourable responses in elderly patients with high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    51. Kollmannsberger, C; Quietzsch, D; Haag, C; Lingenfelser, T; Schroeder, M; Hartmann, JT; Baronius, W; Hempel, V; Clemens, M; Kanz, L; Bokemeyer, C
      A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

      BRITISH JOURNAL OF CANCER
    52. Brossart, P; Wirths, S; Stuhler, G; Reichardt, VL; Kanz, L; Brugger, W
      Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells

      BLOOD
    53. Hartmann, JT; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Fizazi, K; Einhorn, L; Kanz, L; Bokemeyer, C
      Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    54. Kollmannsberger, C; Kuzcyk, M; Mayer, F; Hartmann, JT; Kanz, L; Bokemeyer, C
      Late toxicity following curative treatment of testicular cancer

      SEMINARS IN SURGICAL ONCOLOGY
    55. Daikeler, T; Gunaydin, I; Einsele, H; Kanz, L; Kotter, I
      Transmission of psoriatic arthritis by allogeneic bone marrow transplantation for chronic myelogenous leukaemia from an HLA-identical donor

      RHEUMATOLOGY
    56. Kanz, L; Brossart, P; Stuhler, G; Reichardt, V; Kleihauer, A; Scheding, S; Stevanovic, S; Einsele, H; Rammensee, HG; Brugger, W
      Pre-clinical and early clinical experience using dendritic cells to treat human malignancy

      HEMATOLOGY AND CELL THERAPY
    57. Meister, B; Grunebach, F; Bautz, F; Brugger, W; Fink, FM; Kanz, L; Mohle, R
      Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma

      EUROPEAN JOURNAL OF CANCER
    58. Hartmann, JT; Quietzsch, D; Daikeler, T; Kollmannsberger, C; Mayer, F; Kanz, L; Bokemeyer, C
      Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer

      ANTI-CANCER DRUGS
    59. Kollmannsberger, C; Brugger, W; Hartmann, JT; Maurer, F; Bohm, P; Kanz, L; Bokemeyer, C
      Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma

      ANTI-CANCER DRUGS
    60. Bock, TA; Scheding, S; Brugger, W; Kanz, L
      Clinical use for expanded peripheral blood steam cells

      BAILLIERES CLINICAL HAEMATOLOGY
    61. Crown, J; Coiffier, B; Cortes-Funes, H; Guillaume, T; Kanz, L; Kvalheim, G; Marty, M; Symann, M
      ESTIC position paper: High-dose chemotherapy for breast cancer, investigation should continue

      ANNALS OF ONCOLOGY
    62. Fetscher, S; Brugger, W; Engelhardt, R; Kanz, L; Hasse, J; Frommhold, H; Lange, W; Mertelsmann, R
      Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicinin 100 patients with small-cell lung cancer: A mature follow-up report

      ANNALS OF ONCOLOGY
    63. Fetscher, S; Brugger, W; Engelhardt, R; Kanz, L; Hasse, J; Frommhold, H; Lange, W; Mertelsmann, R
      Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicinin 107 patients with non-small-cell lung cancer: A mature follow-up report

      ANNALS OF ONCOLOGY
    64. Kollmannsberger, C; Pressler, H; Mayer, F; Kanz, L; Bokemeyer, C
      Cisplatin-refractory, HER2/neu-expressing germ-cell cancer: Induction of remission by the monoclonal antibody Trastuzumab

      ANNALS OF ONCOLOGY
    65. Bokemeyer, C; Hartmann, JT; Kollmannsberger, C; Mayer, F; Kanz, L
      UFT/calcium folinate plus weekly paclitaxel for solid tumors

      ONCOLOGY-NEW YORK
    66. Mohle, R; Failenschmid, C; Bautz, F; Kanz, L
      Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)

      LEUKEMIA
    67. Brugger, W; Buhring, HJ; Grunebach, F; Vogel, W; Kaul, S; Muller, R; Brummendorf, TH; Ziegler, BL; Rappold, I; Brossart, P; Scheding, S; Kanz, L
      Expression of MUC-1 epitopes on normal bone marrow: Implications for the detection of micrometastatic tumor cells

      JOURNAL OF CLINICAL ONCOLOGY
    68. Bokemeyer, C; Gerl, A; Schoffski, P; Harstrick, A; Niederle, N; Beyer, J; Casper, J; Schmoll, HJ; Kanz, L
      Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer

      JOURNAL OF CLINICAL ONCOLOGY
    69. Bokemeyer, C; Kollmannsberger, C; Meisner, C; Harstrick, A; Beyer, J; Metzner, B; Hartmann, JT; Schmoll, HL; Einhorn, L; Kanz, L; Nichols, C
      First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis

      JOURNAL OF CLINICAL ONCOLOGY
    70. Hartmann, JT; Kuczyk, MA; Kollmannsberger, C; Kanz, L; Bokemeyer, C
      Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer

      WORLD JOURNAL OF UROLOGY
    71. Hebart, H; Bokemeyer, C; Loffler, J; Schumacher, U; Kanz, L; Einsele, H
      Management of invasive fungal infections in oncological patients

      ONKOLOGIE
    72. Kotter, I; Muller, CA; Einsele, H; Mohren, M; Kanz, L
      Interferon-alpha-associated polyarthritis - Possible induction of seropositive rheumatoid arthritis by interferon-alpha: two case reports and review of the literature

      ZEITSCHRIFT FUR RHEUMATOLOGIE
    73. Scheding, S; Franke, H; Diehl, V; Wichmann, HE; Brugger, W; Kanz, L; Schmitz, S
      How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation? Results of a computer simulation

      EXPERIMENTAL HEMATOLOGY
    74. Bethge, W; Beck, R; Jahn, G; Mundinger, P; Kanz, L; Einsele, H
      Successful treatment of human herpesvirus-6 encephalitis after bone marrowtransplantation

      BONE MARROW TRANSPLANTATION
    75. Wiesmann, A; Weller, A; Lischka, G; Klingebiel, T; Kanz, L; Einsele, H
      Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study

      BONE MARROW TRANSPLANTATION
    76. Gunaydin, I; Terhorst, T; Eckstein, A; Daikeler, T; Kanz, L; Kotter, I
      Assessment of keratoconjunctivitis sicca in patients with fibromyalgia: results of a prospective study

      RHEUMATOLOGY INTERNATIONAL
    77. Gunaydin, I; Daikeler, T; Mohren, M; Kanz, L; Kotter, I
      Lower limb pitting edema in systemic lupus erythematosus

      RHEUMATOLOGY INTERNATIONAL
    78. Beck, R; Westdorp, I; Jahn, G; Schafer, H; Kanz, L; Einsele, H
      Detection of Epstein-Barr virus DNA in plasma from patients with lymphoproliferative disease after allogeneic bone marrow or peripheral blood stem cell transplantation

      JOURNAL OF CLINICAL MICROBIOLOGY
    79. Kollmannsberger, C; Mross, K; Jakob, A; Kanz, L; Bokemeyer, C
      Topotecan - A novel topoisomerase I inhibitor: Pharmacology and clinical experience

      ONCOLOGY
    80. Handgretinger, R; Geiselhart, A; Moris, A; Grau, R; Teuffel, O; Bethge, W; Kanz, L; Fisch, P
      Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors

      NEW ENGLAND JOURNAL OF MEDICINE
    81. Stuhler, G; Zobywalski, A; Grunebach, F; Brossart, P; Reichardt, VL; Barth, H; Stevanovic, S; Brugger, W; Kanz, L; Schlossman, SF
      Immune regulatory loops determine productive interactions within human T lymphocyte dendritic cell clusters

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    82. Mayer, F; Kanz, L
      Stem cell reserve following autologous hematopoietic stem cell transplantation

      INTERNIST
    83. Einsele, H; Kanz, L
      Allogeneic stem-cell transplantation

      INTERNIST
    84. Bokemeyer, C; Kollmannsberger, C; Harstrick, A; Beyer, J; Gerl, A; Casper, J; Metzner, B; Hartmann, JT; Schmoll, HJ; Kanz, L
      Treatment of patients with cisplatin-refractory testicular germ-cell cancer

      INTERNATIONAL JOURNAL OF CANCER
    85. Kollmannsberger, C; Hartmann, JT; Kanz, L; Bokemeyer, C
      Therapy-related malignancies following treatment of germ cell cancer

      INTERNATIONAL JOURNAL OF CANCER
    86. Hartmann, JT; Kollmannsberger, C; Kanz, L; Bokemeyer, C
      Platinum organ toxicity and possible prevention in patients with testicular cancer

      INTERNATIONAL JOURNAL OF CANCER
    87. Hoffken, K; Diehl, V; Kanz, L; Possinger, K; Zander, A; Kreienberg, R; Bender, HG; Elling, D; Jackisch, C; Luck, HJ; Mobus, V; Nitz, U; Thomssen, C; Untch, M; Gaisser, A
      High dose treatment of mammary carcinoma. "Wait and see" is the reaction to the results of the randomized studies presented at the ASCO 1999 in Atlanta

      GYNAKOLOGE
    88. Hartmann, JT; Kanz, L; Bokemeyer, C
      Diagnosis and treatment of patients with testicular germ cell cancer

      DRUGS
    89. Schmitz, K; Brugger, W; Weiss, B; Kaiserling, E; Kanz, L
      Clonal selection of CD20-negative non-Hodgkin's lymphoma cells after treatment with anti-CD20 antibody rituximab

      BRITISH JOURNAL OF HAEMATOLOGY
    90. Buhring, HJ; Simmons, PJ; Pudney, M; Muller, R; Jarrossay, D; van Agthoven, A; Willheim, M; Brugger, W; Valent, P; Kanz, L
      The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors

      BLOOD
    91. Vogel, W; Kanz, L; Brugger, W; Berndt, A; Kosmehl, H
      Expression of laminin beta 2 chain in normal human bone marrow

      BLOOD
    92. Buhring, HJ; Seiffert, M; Marxer, A; Weiss, B; Faul, C; Kanz, L; Brugger, W
      AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34(+) B-cell precursors

      BLOOD
    93. Brossart, P; Spahlinger, B; Grunebach, F; Stuhler, G; Reichardt, VL; Kanz, L; Brugger, W
      Induction of minor histocompatibility antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantation

      BLOOD
    94. Seiffert, M; Cant, C; Chen, ZJ; Rappold, I; Brugger, W; Kanz, L; Brown, EJ; Ullrich, A; Buhring, HJ
      Human signal-regulatory protein is expressed on normal, but not on subsetsof leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47

      BLOOD
    95. Brossart, P; Heinrich, KS; Stuhler, G; Behnke, L; Reichardt, VL; Stevanovic, S; Muhm, A; Rammensee, HG; Kanz, L; Brugger, W
      Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies

      BLOOD
    96. Ziegler, BL; Muller, R; Valtieri, M; Lamping, CP; Thomas, CA; Gabbianelli, M; Giesert, C; Buhring, HJ; Kanz, L; Peschle, C
      Unicellular-unilineage erythropoietic cultures: Molecular analysis of regulatory gene expression at sibling cell level

      BLOOD
    97. Scheding, S; Brugger, W; Kanz, L
      Autologous stem cell transplantation and manipulation

      TEXTBOOK OF MALIGNANT HAEMATOLOGY
    98. SHARKIS S; KANZ L; BRUGGER N; ORLIC D
      THE FASCINATING LIFE OF HEMATOPOIETIC STEM-CELLS

      Nature medicine
    99. HARTMANN JT; HARSTRICK A; DAIKELER T; KOLLMANNSBERGER C; MULLER C; SEEBER S; KANZ L; BOKEMEYER C
      PHASE-II STUDY OF CONTINUOUS 120 H INFUSION OF MITOMYCIN-C AS SALVAGECHEMOTHERAPY IN PATIENTS WITH PROGRESSIVE OR RAPIDLY RECURRENT COLORECTAL-CANCER

      Anti-cancer drugs
    100. KOLLMANNSBERGER C; QUIETZCH D; CLEMENS M; LAMPE C; LINGENFELSER T; HARTMANN JT; KANZ L; BOKEMEYER C
      A PHASE-II TRIAL OF PACLITAXEL, CISPLATIN, AND WEEKLY 24 H INFUSION OF 5-FLUOROURACIL (5-FU) FOLINIC ACID (FA) IN PATIENTS (PTS) WITH ADVANCED GASTRIC-CANCER/

      Annals of oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/02/20 alle ore 19:30:10